Table 4. Survival of AL patients... | American Society of Hematology

Table 4.

Survival of AL patients estimated by the combined consideration of prognostic factors

Prognostic factors^4-150	Both favorable		Mixed favorable		Both unfavorable		P
Prognostic factors^4-150	No.	MS, mo	No.	MS, mo	No.	MS, mo	P
PBPC% and BMPC%	88	37.5	50	15.5	9	10.0	.0003
Serum β₂-microglobulin level and BMPC%	31	54.0	55	19.0	32	13.5	.008

Prognostic factors^4-150	Both favorable		Mixed favorable		Both unfavorable		P
Prognostic factors^4-150	No.	MS, mo	No.	MS, mo	No.	MS, mo	P
PBPC% and BMPC%	88	37.5	50	15.5	9	10.0	.0003
Serum β₂-microglobulin level and BMPC%	31	54.0	55	19.0	32	13.5	.008

F4-150

PBPC% of 1% or less is defined as favorable; PBPC% higher than 1%, unfavorable; BMPC% of 10% or less, favorable; BMPC% higher than 10%, unfavorable; serum β₂-microglobulin level less than 2.7 μg/mL, favorable; serum β₂-microglobulin level 2.7 μg/mL or higher, unfavorable.

View Large

This Feature Is Available To Subscribers Only